New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs
The DOI matches its Crossref record; 127 of the 128 references it cites were found in a registry or an index.
Abstract
Poly(ADP-ribose) polymerases (PARPs) are enzymes that transfer ADP-ribose groups to target proteins and thereby affect various nuclear and cytoplasmic processes. The activity of PARP family members, such as PARP1 and PARP2, is tied to cellular signalling pathways, and through poly(ADP-ribosyl)ation (PARylation) they ultimately promote changes in gene expression, RNA and protein abundance, and the location and activity of proteins that mediate signalling responses. PARPs act in a complex response network that is driven by the cellular, molecular and chemical biology of poly(ADP-ribose) (PAR). This PAR-dependent response network is crucial for a broad array of physiological and pathological responses and thus is a good target for chemical therapeutics for several diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Activated PARP1 will consume NAD+, generating PAR through a process called PARylation82.”
From Mitochondrial and metabolic dysfunction in ageing and age-related diseases (2022) · cites this paper as [82]
Citations
Cites
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Bryant, H. E., Schultz, N., Thomas, H. D., Parker, K. M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N. J., & Helleday, T. (2005) · Nature · doi:10.1038/nature03443 · Cited by 5,198
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers
Fong, P. C., Boss, D. S., Yap, T. A., Tutt, A., Wu, P., Mergui-Roelvink, M., Mortimer, P., Swaisland, H., Lau, A., O'Connor, M. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900212 · Cited by 3,634
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
Huang, S.-M. A., Mishina, Y. M., Liu, S., Cheung, A., Stegmeier, F., Michaud, G. A., Charlat, O., Wiellette, E., Zhang, Y., Wiessner, S., et al. (2009) · Nature · doi:10.1038/nature08356 · Cited by 2,037
Poly(ADP-ribose): novel functions for an old molecule
Schreiber, V., Dantzer, F., Ame, J.-C., & de Murcia, G. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1963 · Cited by 1,915
Mediation of Poly(ADP-Ribose) Polymerase-1-Dependent Cell Death by Apoptosis-Inducing Factor
Yu, S.-W., Wang, H., Poitras, M. F., Coombs, C., Bowers, W. J., Federoff, H. J., Poirier, G. G., Dawson, T. M., & Dawson, V. L. (2002) · Science · doi:10.1126/science.1072221 · Cited by 1,826
Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions
d'AMOURS, D., DESNOYERS, S., d'SILVA, I., & POIRIER, G. G. (1999) · Biochemical Journal · doi:10.1042/bj3420249 · Cited by 1,815
PARP inhibition: PARP1 and beyond
Rouleau, M., Patel, A., Hendzel, M. J., Kaufmann, S. H., & Poirier, G. G. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2812 · Cited by 1,298
Gelmon, K. A., Tischkowitz, M., Mackay, H., Swenerton, K., Robidoux, A., Tonkin, K., Hirte, H., Huntsman, D., Clemons, M., Gilks, B., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70214-5 · Cited by 1,117
Tankyrase, a Poly(ADP-Ribose) Polymerase at Human Telomeres
Smith, S., Giriat, I., Schmitt, A., & de Lange, T. (1998) · Science · doi:10.1126/science.282.5393.1484 · Cited by 1,012
Cited by
Items 501–600 of 1,000
Zhang, L., Zhen, Y., Lu, F., Li, Z., Lü, Y., Wang, G., & Ouyang, L. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115648 · Cited by 33
Michels, J., Adam, J., Goubar, A., Obrist, F., Damotte, D., Robin, A., Alifano, M., Vitale, I., Olaussen, K. A., Girard, P., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv393 · Cited by 31
Moustakim, M., Riedel, K., Schuller, M., Gehring, A. P., Monteiro, O., Martin, S. P., Fedorov, O., Heer, J. P., Dixon, D. J., Elkins, J. M., et al. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.03.020 · Cited by 31
“SAR studies of carbazoles GeA-69 (1) and 2.”
BackgroundMethodInfluentialRegulation of Poly(ADP-Ribose) Polymerase 1 Activity by Y-Box-Binding Protein 1
Naumenko, K. N., Sukhanova, M. V., Hamon, L., Kurgina, T. A., Alemasova, E. E., Kutuzov, M. M., Pastré, D., & Lavrik, O. I. (2020) · Biomolecules · doi:10.3390/biom10091325 · Cited by 31
“Many proteins can potentially affect PARP activity through a direct interaction with DNA or PAR polymers, which act as a scaffold molecule and facilitate the formation of a complex between PARPs and proteins [1,8,70,71].”
BackgroundTherapeutic Potential of Emerging NAD+-Increasing Strategies for Cardiovascular Diseases
Rotllán, N., Camacho, M., Tondo, M., Diarte‐Añazco, E. M. G., Canyelles, M., Méndez‐Lara, K. A., Benítez, S., Alonso, N., Mauricio, D., Escolá‐Gil, J. C., et al. (2021) · Antioxidants · doi:10.3390/antiox10121939 · Cited by 34
Protein and RNA ADP-ribosylation detection is influenced by sample preparation and reagents used
Weixler, L., Ikenga, N. J., Voorneveld, J., Aydın, G., Bolte, T. M. H. R., Momoh, J., Bütepage, M., Golzmann, A., Lüscher, B., Filippov, D. V., et al. (2022) · Life Science Alliance · doi:10.26508/lsa.202201455 · Cited by 32
“ADP-ribosylation is a posttranslational modi fi cation, which is mediated in cells by ADP-ribosyltransferases (ARTs) of the ARTD family, which add ADP-ribose (ADPr) to their targets while releasing nicotinamide from co-factor NAD + (Gibson & Kraus, 2012; Luscher et al, 2018).”
Coupling bimolecular PARylation biosensors with genetic screens to identify PARylation targets
Krastev, D. B., Pettitt, S. J., Campbell, J., Song, F., Tanos, B. E., Stoynov, S., Ashworth, A., & Lord, C. J. (2018) · Nature Communications · doi:10.1038/s41467-018-04466-4 · Cited by 33
“3a): (1) by replacing the IRES-GFP sequences with a VC-coding sequence, generating a SA-VC-polyA cassette; (2) by generating three different open reading frames of the resultant transposon (UPATrap-VC 1, 2, and 3); and (3) by removing the IRES sequence in the NeoR cassette.”
BackgroundMethodPourfarjam, Y., Ventura, J., Kurinov, I. V., Cho, A., Moss, J., & Kim, I. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003586 · Cited by 31
“Regulation of poly(ADP-ribosyl)ation (PARylation),(4) a reversible post-translational modification (PTM) of proteins, is required for maintaining genomic integrity and cellular responses to DNA damage (1, 2).”
BackgroundMackay, D. R., Howa, A. C., Werner, T. L., & Ullman, K. S. (2017) · Journal of Cell Science · doi:10.1242/jcs.203513 · Cited by 31
“This challenge to the simple paradigm that PARPi toxicity always relies on NHEJ may be explained by other activities that have been ascribed to PARP enzymes (Gibson and Kraus, 2012; Gibson et al., 2016) or a route of NHEJ that does not rely on 53BP1.”
BackgroundGeng, L., Zhu, M., Luo, D., Chen, H., Li, B., Lao, Y., An, H., Wu, Y., Li, Y., Xia, A., et al. (2024) · Oncogene · doi:10.1038/s41388-023-02935-9 · Cited by 31
“This post-translational modi fi cation, known as PARylation, not only regulates protein function but also recruits additional proteins to damaged sites for aiding of DNA repair [29].”
BackgroundIdentification of ADP-ribosylated peptides and ADP-ribose acceptor sites
Rosenthal, F. (2014) · Frontiers in bioscience · doi:10.2741/4266 · Cited by 31
“Macrodomains The macrodomain consists of 130-160 amino acids and displays a mixed a/ß-fold that is conserved in over 300 currently known macrodomain-containing proteins from viruses and bacteria to humans (23, 44).”
BackgroundInfluentialPARP1 depletion induces RIG-I-dependent signaling in human cancer cells
Ghosh, R., Roy, S., & Franco, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194611 · Cited by 32
Hypothalamic NAD+-Sirtuin Axis: Function and Regulation
Roh, E., & Kim, M. (2020) · Biomolecules · doi:10.3390/biom10030396 · Cited by 30
Coordinated regulation of plant immunity by poly(ADP-ribosyl)ation and K63-linked ubiquitination
Yao, D., Arguez, M. A., He, P., Bent, A. F., & Song, J. (2021) · Molecular Plant · doi:10.1016/j.molp.2021.08.013 · Cited by 30
Linking DNA repair and cell cycle progression through serine ADP-ribosylation of histones
Brustel, J., Muramoto, T., Fumimoto, K., Ellins, J., Pears, C. J., & Lakin, N. D. (2022) · Nature Communications · doi:10.1038/s41467-021-27867-4 · Cited by 34
Discovery of an NAD + analogue with enhanced specificity for PARP1
Zhang, X., Lam, A. T., Cheng, Q., Courouble, V. V., Strutzenberg, T. S., Li, J., Wang, Y., Pei, H., Stiles, B. L., Louie, S. G., et al. (2022) · Chemical Science · doi:10.1039/d1sc06256e · Cited by 32
Das, P. K., Matada, G. S. P., Pal, R., Maji, L., Dhiwar, P. S., Manjushree, B. V., & Viji, M. P. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116535 · Cited by 35
Cheong, W.-C., Park, J.-H., Kang, H.-R., & Song, M. J. (2015) · Journal of Virology · doi:10.1128/jvi.00559-15 · Cited by 30
Analysis of Poly(ADP-Ribose) Polymerases in Arabidopsis Telomere Biology
Boltz, K. A., Jasti, M., Townley, J. M., & Shippen, D. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088872 · Cited by 33
“PARylation can alter the function of proteins in several ways [29].”
BackgroundChemoselective Dimerization of Phosphates
Hofer, A., Marques, E., Kieliger, N., Gatter, S.-K. N., Jordi, S., Ferrari, E., Hofmann, M., Fitzpatrick, T. B., Hottiger, M. O., & Jessen, H. J. (2016) · Organic Letters · doi:10.1021/acs.orglett.6b01466 · Cited by 30
Korkmaz‐Icöz, S., Szczęsny, B., Marcatti, M., Li, S., Ruppert, M., Lasitschka, F., Loganathan, S., Szabó, C., & Szabo, G. B. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13983 · Cited by 32
“Although it is primarily studied in the nucleus (Virág and Szabó, 2002; Jagtap and Szabó, 2005; Gibson and Kraus, 2012; Gupte et al., 2017), emerging evidence also demonstrates its localization and multiple roles in mitochondria (see Brunyanszki et al.”
BackgroundRavindranathan, R., Somuncu, O., da Costa, A. A. B. A., Mukkavalli, S., Lamarre, B. P., Nguyen, H. Q., Grochala, C., Jiao, Y., Liu, J. F., Kochupurakkal, B. S., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2413954121 · Cited by 32
“PARylation (Poly - ADP - Ribosylation), a reversible post - translational modification of proteins, is one of the earliest waves of signaling at DNA lesions and a critical event in DNA damage response (DDR) and repair process ( 1 , 2 ).”
Acute sources of mitochondrial NAD+ during respiratory chain dysfunction
Chinopoulos, C. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113218 · Cited by 29
A poly-ADP-ribose polymer-based antibody-drug conjugate
Shi, X., Zhang, X., Chen, J., Cheng, Q., Pei, H., Louie, S. G., & Zhang, Y. (2020) · Chemical Science · doi:10.1039/d0sc01795g · Cited by 30
A Novel Role for the DNA Repair Enzyme 8-Oxoguanine DNA Glycosylase in Adipogenesis
Komakula, S. S. B., Blaze, B., Ye, H., Dobrzyń, A., & Sampath, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031152 · Cited by 30
“Activation of PARP1 results in post-translational modification of proteins via the addition of poly ADP ribose moieties [39].”
BackgroundLin, S., Tu, G., Yu, Z., Jiang, Q., Zhang, L., Liu, J., Liu, Q., Huang, X., Xu, J., Lin, Y., et al. (2022) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2022.116912 · Cited by 30
Cunliffe, V. T. (2015) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1291 · Cited by 32
NAD metabolism in aging and cancer
Kincaid, J. W. R., & Berger, N. A. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220929287 · Cited by 31
“At least five mARTs (ART1–5) have been identified in mammalian tissues,(5) including cardiac and skeletal muscle, brain, testes, and hematologic, including erythrocytes, platelets, and lymphocytes, where their function may be further defined by subcellular location.(5,81,85) Avariety of acceptor proteins have likewise…”
BackgroundInfluentialPARP and other prospective targets for poisoning cancer cell metabolism
Michels, J., Obrist, F., Castedo, M., Vitale, I., & Kroemer, G. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.08.026 · Cited by 29
Nicotinamide N -Methyltransferase in Health and Cancer
Ramsden, D. B., Waring, R. H., Barlow, D. J., & Parsons, R. B. (2017) · International Journal of Tryptophan Research · doi:10.1177/1178646917691739 · Cited by 29
Grimaldi, G., Catara, G., Palazzo, L., Corteggio, A., Valente, C., & Corda, D. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.05.019 · Cited by 28
PROTACs in gastrointestinal cancers
Chen, Y., Yang, Q., Xu, J., Tang, L., Zhang, Y., Du, F., Zhao, Y., Wu, X., Li, M., Shen, J., et al. (2022) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2022.10.012 · Cited by 30
“PARP-1 is a protein containing a zinc-finger structure that binds to double-stranded or single-stranded DNA broken strands.(195) When bound to DNA broken strands, PARP-1 mediates DNA replication, recombination, and repair.”
BackgroundA PARP1-ERK2 synergism is required for the induction of LTP
Visochek, L., Grigoryan, G., Kalal, A. A., Milshtein-Parush, H., Gazit, N., Slutsky, I., Yeheskel, A., Shainberg, A., Castiel, A., Seger, R., et al. (2016) · Scientific Reports · doi:10.1038/srep24950 · Cited by 30
Identification of Poly(ADP-Ribose) Polymerase Macrodomain Inhibitors Using an AlphaScreen Protocol
Ekblad, T., Verheugd, P., Lindgren, A. E. G., Nyman, T., Elofsson, M., & Schuler, H. (2018) · SLAS DISCOVERY · doi:10.1177/2472555217750870 · Cited by 28
“ADP-ribosylation is a posttranslational modification that regulates a multitude of vital processes.(1,2) Intracellular monoand poly-ADP-ribosylation (MARylation and PARylation) are catalyzed by two different subclasses of the poly(ADPribose) polymerase (PARP) family, enzymes also known as ADP-ribosyltransferases with…”
BackgroundMultiple functions of PARP1 in the repair of DNA double strand breaks
Ortega, R., Bitler, B. G., & Arnoult, N. (2025) · DNA repair · doi:10.1016/j.dnarep.2025.103873 · Cited by 29
Disruption of Macrodomain Protein SCO6735 Increases Antibiotic Production in Streptomyces coelicolor
Lalić, J., Marjanović, M. P., Palazzo, L., Perina, D., Sabljić, I., Žaja, R., Colby, T., Pleše, B., Halasz, M., Jankevicius, G., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.721894 · Cited by 27
“protein degradation, apoptosis and necrosis (1-5).”
Conrad, L. B., Lin, K. Y., Nandu, T. S., Gibson, B. A., Lea, J. S., & Kraus, W. L. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0569 · Cited by 27
“, automodification) and other substrate proteins (17, 18).”
BackgroundSelf-citationMolecular docking based virtual screening of the breast cancer target NUDT5
Sultana, R. (2019) · Bioinformation · doi:10.6026/97320630015784 · Cited by 27
Chloroquine Triggers Cell Death and Inhibits PARPs in Cell Models of Aggressive Hepatoblastoma
Eloranta, K., Cairo, S., Liljeström, E., Soini, T., Kyrönlahti, A., Judde, J., Wilson, D. B., Heikinheimo, M., & Pihlajoki, M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01138 · Cited by 27
Photosensitivity and cGAS-Dependent IFN-1 Activation in Patients with Lupus and TREX1 Deficiency
Berndt, N., Wolf, C., Fischer, K., Costa, E. C., Knuschke, P., Zimmermann, N., Schmidt, F., Merkel, M., Chara, O., Lee‐Kirsch, M. A., et al. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2021.04.037 · Cited by 27
Zhou, J., Ji, M., Wang, X., Zhao, H., Cao, R., Jin, J., Li, Y., Chen, X., Li, S., Chen, X., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01522 · Cited by 27
Samarskaya, V. O., Spechenkova, N. A., Маркин, Н. В., Suprunova, T. P., Завриев, С. К., Love, A. J., Kalinina, N. O., & Taliansky, M. E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147915 · Cited by 28
Tumor metabolism rewiring in epithelial ovarian cancer
Wang, M., Zhang, J., & Wu, Y. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-023-01196-0 · Cited by 33
Parp3 Negatively Regulates Immunoglobulin Class Switch Recombination
Robert, I., Gaudot, L., Rogier, M., Heyer, V., Noll, A., Dantzer, F., & Reina‐San‐Martin, B. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005240 · Cited by 29
Poly(ADP-ribose)-binding promotes Exo1 damage recruitment and suppresses its nuclease activities
Cheruiyot, A., Paudyal, S. C., Kim, I.-K., Sparks, M. A., Ellenberger, T., Piwnica-Worms, H. M., & You, Z. (2015) · DNA repair · doi:10.1016/j.dnarep.2015.09.021 · Cited by 29
Kırıcı, M., Nedzvetsky, V. S., Ağca, C. A., & Gasso, V. Y. (2019) · Regulatory Mechanisms in Biosystems · doi:10.15421/021916 · Cited by 27
Sutcu, H. H., Matta, E., & Ishchenko, A. A. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.12.019 · Cited by 29
“Similar to PARP1 and PARP2, PARP3 is an important player in cell cycle regulation and DNA repair [38].”
BackgroundThe ARH and Macrodomain Families of α-ADP-ribose-acceptor Hydrolases Catalyze α-NAD+ Hydrolysis
Stevens, L. A., Kato, J., Kasamatsu, A., Oda, H., Lee, D., & Moss, J. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00429 · Cited by 26
Gadad, S. S., Camacho, C. V., Malladi, V. S., Hutti, C. R., Nagari, A., & Kraus, W. L. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-21-0103 · Cited by 26
Self-citationBlue, Y. A., Kusumi, J., & Satake, A. (2020) · iScience · doi:10.1016/j.isci.2021.102779 · Cited by 30
Targeting cancer stem cells in the tumor microenvironment: An emerging role of PARP inhibitors
Paul, S., Sinha, S., & Kundu, C. N. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106425 · Cited by 27
PARP1 recruits DNA translocases to restrain DNA replication and facilitate DNA repair
Ho, Y.-C., Ku, C.-S., Tsai, S.-S., Shiu, J.-L., Jiang, Y., Miriam, H. E., Zhang, H., Chen, Y., Chiu, W., Chang, S., et al. (2022) · PLoS Genetics · doi:10.1371/journal.pgen.1010545 · Cited by 28
“BER requires poly (ADP-ribose) polymerase I (PARP1), which catalyzes the formation of poly (ADP-ribose) (PAR) onto itself and target proteins [13,14].”
Cell fate regulation by chromatin ADP-ribosylation
Abplanalp, J., & Hottiger, M. O. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.09.010 · Cited by 27
Inhibition of Poly(ADP-Ribose) Polymerase-1 Protects Chronic Alcoholic Liver Injury
Zhang, Y., Wang, C., Tian, Y., Zhang, F., Xu, W., Li, X., Shu, Z., Wang, Y., Huang, K., & Huang, D. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.08.016 · Cited by 26
“identified genes that transcribe PARPs.(9) It can be activated by DNA strand breaks attributable to reactive oxygen species, which is generated at high levels under oxidative stress, thus leading to cellular damage and stimulating proinflammatory mediator production.”
BackgroundChen, W., Guo, N., Qi, M., Dai, H., Hong, M., Guan, L., Huan, X., Song, S., He, J., Wang, Y.-Q., et al. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.06.053 · Cited by 27
Wang, M., Yuan, Z., Xie, R., Ma, Y., Liu, X., & Yu, X. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004284 · Cited by 27
Nonspecific Binding of RNA to PARP1 and PARP2 Does Not Lead to Catalytic Activation
Nakamoto, M. Y., Rudolph, J., Wuttke, D. S., & Luger, K. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00986 · Cited by 26
Dhoonmoon, A., Schleicher, E. M., Clements, K. E., Nicolae, C. M., & Moldovan, G. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa508 · Cited by 33
Identification of novel PARP-1 inhibitors by structure-based virtual screening
Hannigan, K., Kulkarni, S. S., Bdzhola, V. G., Golub, A. G., Yarmoluk, S. M., & Talele, T. T. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.09.007 · Cited by 28
Trial watch – inhibiting PARP enzymes for anticancer therapy
Sistigu, A., Manic, G., Obrist, F., & Vitale, I. (2015) · Molecular & Cellular Oncology · doi:10.1080/23723556.2015.1053594 · Cited by 26
“chemotherapy regimens) is being assessed (1) in 7 phase III tri-”
InfluentialJang, K.-H., Hwang, Y., & Kim, E. (2020) · PubMed Central · doi:10.14348/molcells.2020.0078 · Cited by 28
“Poly(ADP-ribose) polymerase (PARP) 1 is a member of the PARP enzyme family, which catalyzes the transfer of ADP-ribose onto target proteins using NAD + (Abd Elmageed et al., 2012; Gibson and Kraus, 2012).”
PARP Inhibitors in Cancer Therapy: Magic Bullets but Moving Targets
Shah, G. M., Robu, M., Purohit, N. K., Rajawat, J., Tentori, L., & Graziani, G. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00279 · Cited by 27
Mashimo, M., & Moss, J. (2016) · Current Protein and Peptide Science · doi:10.2174/1389203717666160419144603 · Cited by 27
Long, A., Klimova, N., & Kristián, T. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.03.009 · Cited by 28
Zhang, Y., Liao, X.-H., Xie, H.-Y., Shao, Z., & Li, D. (2017) · Oncotarget · doi:10.18632/oncotarget.21784 · Cited by 26
“One key regulator of the cellular response to DNA damage is the poly(ADP-ribose) polymerase 1 (PARP1), the most abundant and founding member of the PARP family [3, 4].”
BackgroundChen, X., Yang, D., Carey, J. P. W., Karakaş, C., Albarracin, C. T., Şahin, A. A., Arun, B., Durak, M. G., Li, M., Kohansal, M., et al. (2021) · Cancers · doi:10.3390/cancers13071656 · Cited by 27
“PAR protein is rapidly synthesized by PAR polymerases (PARPs) upon activation of DNA single and double strand breaks [55].”
BackgroundEZH2 directly methylates PARP1 and regulates its activity in cancer
Meng, Q., Shen, J., Ren, Y., Liu, Q., Wang, R., Li, Q., Jiang, W., Wang, Q., Zhang, Y., Trinidad, J. C., et al. (2024) · Science Advances · doi:10.1126/sciadv.adl2804 · Cited by 27
“PARP1 is the most abundant member of the PARP superfamily and plays important roles in DNA repair and genomic stability ( 4 ).”
Kayumov, M., Li, J., Pardaev, A., Song, S., Mirzaakhmedov, S. Y., Ding, C., Cheng, Y.-J., Zhang, R., Bao, X., Miao, Z., et al. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114574 · Cited by 28
PARP inhibitors in small cell lung cancer: The underlying mechanisms and clinical implications
Wang, X., Zeng, X., Li, D., Zhu, C., Guo, X., Feng, L., & Yu, Z. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113458 · Cited by 29
NAD+, Sirtuins and PARPs: enhancing oocyte developmental competence
Pollard, C., Gibb, Z., Swegen, A., & Grupen, C. G. (2022) · Journal of Reproduction and Development · doi:10.1262/jrd.2022-052 · Cited by 27
An Overview of PARP Resistance in Ovarian Cancer from a Molecular and Clinical Perspective
Cordani, N., Bianchi, T., Ammoni, L. C., Cortinovis, D. L., Cazzaniga, M. E., Lissoni, A. A., Landoni, F., & Canova, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241511890 · Cited by 25
“On the other hand, PARP3 catalyzes mono (ADP)-ribosylation [12].”
BackgroundInvolvement of PARPs in cell death
Aredia, F., & Scovassi, A. I. (2014) · Frontiers in Bioscience-Elite · doi:10.2741/707 · Cited by 25
“It is regulated by a superfamily of 17 poly(ADPribose) polymerases (PARPs), which synthesize a polymer of ADP-ribose (PAR) from NAD, releasing nicotinamide and protons (2-3).”
BackgroundGhosh, R., Roy, S., Kamyab, J., Dantzer, F., & Franco, S. (2016) · DNA repair · doi:10.1016/j.dnarep.2016.06.001 · Cited by 27
“Poly(ADP-ribos)ylation (PARylation) is a ubiquitous posttranslational modification that regulates DNA damage signaling and repair, transcription and other cellular processes [1-3].”
BackgroundLi, X., Wu, Z., Xiao-jing, A., Mei, Q., Bai, M., Hanski, L. L., Li, X., Ahola, T., & Han, W. (2017) · eLife · doi:10.7554/elife.27301 · Cited by 24
“Beyond its indispensable role in DNA repair (Gibson and Kraus, 2012), emerging evidence reveals that PARP1-mediated PARylation is one of the most crucial PTMs orchestrating DNA-damage-initiated NF-kB signaling (Stilmann et al., 2009).”
BackgroundCHK2-mediated regulation of PARP1 in oxidative DNA damage response
Hsu, P.-C., Gopinath, R. K., Hsueh, Y.-A., & Shieh, S.-Y. (2018) · Oncogene · doi:10.1038/s41388-018-0506-7 · Cited by 25
The MacroH2A1.1 – PARP1 Axis at the Intersection Between Stress Response and Metabolism
Hurtado-Bagès, S., Guberović, I., & Buschbeck, M. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00417 · Cited by 25
Howard, R. T., HEMSLEY, P. E., Petteruti, P., Saunders, C. N., Bermejo, J. A. M., Scott, J. S., Johannes, J. W., & Tate, E. W. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.9b00963 · Cited by 25
Therapeutic Strategies and Biomarkers to Modulate PARP Activity for Targeted Cancer Therapy
Singh, N., Pay, S. L., Bhandare, S. B., Arimpur, U., & Motea, E. A. (2020) · Cancers · doi:10.3390/cancers12040972 · Cited by 25
PARP1 orchestrates variant histone exchange in signal‐mediated transcriptional activation
O’Donnell, A., Yang, S., & Sharrocks, A. D. (2013) · EMBO Reports · doi:10.1038/embor.2013.164 · Cited by 28
“PARP1 catalyses the deposition of poly ADP-ribose (PAR) on substrate proteins with the main recipient being PARP1 itself in an automodification reaction [6].”
Targeting PARP1: A Promising Approach for Next-Generation Poly (ADP-ribose) Polymerase Inhibitors
Ray, A., & Opyrchal, M. (2025) · Current Breast Cancer Reports · doi:10.1007/s12609-025-00582-5 · Cited by 26
“PARP1 and PARP2 are well characterized for their role in DNA damage repair, ensuring cell survival by modifying proteins involved in chromatin architecture and DNA repair processes [5, 7, 8].”
Corte, L. D., Foreste, V., Filippo, C. D., Giampaolino, P., & Bifulco, G. (2021) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2021.1901882 · Cited by 23
“homologous recombination pathway (HR) which is deficient in BRCA-mutated cells [17].”
BackgroundKanakkanthara, A., Hou, X., Ekstrom, T. L., Zanfagnin, V., Huehls, A. M., Kelly, R. L., Ding, H., Larson, M. C., Vasmatzis, G., Oberg, A. L., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-0732 · Cited by 25
DNA Damage Repair: Predictor of Platinum Efficacy in Ovarian Cancer?
Stefanou, D. T., Souliotis, V. L., Zakopoulou, R., Liontos, M., & Bamias, A. (2021) · Biomedicines · doi:10.3390/biomedicines10010082 · Cited by 26
“The PARP enzymes are involved in a variety of cellular processes that govern energy consumption as well as gene transcription, cell death, and epigenetic alterations [78].”
BackgroundPBX1-SIRT1 Positive Feedback Loop Attenuates ROS-Mediated HF-MSC Senescence and Apoptosis
Wang, Y., Sui, Y., Niu, Y., Liu, D., Xu, Q., Liu, F., Zuo, K., Liu, M., Sun, W., Wang, Z., et al. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-022-10425-w · Cited by 23
“PARP1 is generally regarded as a DNA damage repair enzyme that exerts a protective effect by recruiting repair-related proteins to sites with minor DNA damage to facilitate DNA damage repair [34].”
BackgroundProteome-wide microarray-based screening of PAR-binding proteins
Kang, B. G., Kang, S.-U., Kim, J. J., Kwon, J.-S., Gagné, J., Lee, S. Y., Kim, S., Lee, K. S., Ha, S., Jeong, J. S., et al. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf300 · Cited by 26
“PAR readers span several functions including the regulation of mitosis, cell death and chromatin modification, among others [ 1 , 6 , 9–11 ].”
Sun, S., Shen, H., Liu, C., & Li, Z. (2015) · The Analyst · doi:10.1039/c5an00963d · Cited by 23
Salmas, R. E., Ünlü, A., Yurtsever, M., Noskov, S. Y., & Durdağı, S. (2015) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2015.1005011 · Cited by 23
Site-specific ADP-ribosylation of histone H2B in response to DNA double strand breaks
Rakhimova, A., Ura, S., Hsu, D., Wang, H., Pears, C. J., & Lakin, N. D. (2017) · Scientific Reports · doi:10.1038/srep43750 · Cited by 23
Shuhendler, A. J., Cui, L., Chen, Z., Shen, B., Chen, M., James, M. L., Witney, T. H., Bazalova‐Carter, M., Gambhir, S. S., Chin, F. T., et al. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00089 · Cited by 23
Targeting ADP-ribosylation by PARP inhibitors in acute myeloid leukaemia and related disorders
Faraoni, I., Giansanti, M., Voso, M. T., Lo‐Coco, F., & Graziani, G. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.04.019 · Cited by 24
PARP inhibition causes premature loss of cohesion in cancer cells
Kukolj, E., Kaufmann, T., Dick, A. E., Zeillinger, R., Gerlich, D. W., & Slade, D. (2017) · Oncotarget · doi:10.18632/oncotarget.21879 · Cited by 23
“PAR―a short-lived post-translational modification―is an ideal mediator of dynamic cellular processes based on the formation of interaction scaffolds or the disruption of protein-protein and protein-DNA interactions [5].”
Ibrahim, A., Fros, J. J., Bertran, A. G. M., Sechan, F., Odon, V., Torrance, L., Kormelink, R., & Peter Simmonds, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-54853-0 · Cited by 24
Development and characterization of new tools for detecting poly(ADP-ribose) in vitro and in vivo
Challa, S., Ryu, K. W., Whitaker, A. L., Abshier, J. C., Camacho, C. V., & Kraus, W. L. (2022) · eLife · doi:10.7554/elife.72464 · Cited by 26
Self-citationXRCC1 mediates PARP1- and PAR-dependent recruitment of PARP2 to DNA damage sites
Lin, X. S., Leung, K. S. K., Wolfe, K. F., Call, N., Bhandari, S. K., Huang, X., Lee, B. J., Tomkinson, A. E., & Zha, S. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf086 · Cited by 22
“DNA strand breaks activate poly-ADP-ribose polymerase 1 (PARP1) and PARP2, which uses nicotinamide adenine dinucleotide (NAD+) as a donor to conjugate ADP-ribose (ADPr) on protein substrates, including themselves and histones [ 1 , 2 ].”
Bashyal, A., & Brodbelt, J. S. (2022) · Mass Spectrometry Reviews · doi:10.1002/mas.21811 · Cited by 23
Sun, H., Liu, C., Han, F., Lin, X., Cao, L., Liu, C., Ji, Q., Cui, J., Yao, Y., Wang, B., et al. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01118-z · Cited by 24
“PARylation most commonly takes place on aspartate (D), glutamate (E) and lysine (K) residues of target proteins [26].”
BackgroundMethodGuo, P., Wang, J., Liu, J., Xia, M., Li, W., & He, M. (2015) · Tumor Biology · doi:10.1007/s13277-015-3161-4 · Cited by 25
“Poly-ADP-ribose polymerase (PARP) is a nuclear protein with an ADP-ribosyl transferase catalytic domain with multiple cellular functions including transcriptional regulation, DNA damage repair, cell proliferation, and apoptosis [23, 24].”
BackgroundBase Excision Repair and Nucleotide Excision Repair
Izumi, T., & Mellon, I. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803309-8.00017-3 · Cited by 27
Therapeutic considerations of PARP in stem cell biology: Relevance in cancer and beyond
Zeniou, M., Nguekeu-Zebaze, L., & Dantzer, F. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.06.012 · Cited by 26
Probing the Conformational Changes Associated with DNA Binding to PARP1
Rudolph, J., Mahadevan, J., & Luger, K. (2020) · Biochemistry · doi:10.1021/acs.biochem.0c00256 · Cited by 23
Metadata
- Authors
- Gibson, B. A., & Kraus, W. L.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Kraus, W. Lee
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2012-06-20
- Volume
- 13
- Issue
- 7
- Pages
- 411-424
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W1965006127
- Cited by
- 1,226
- References
- 128
- Citations by year
- 2026: 58 · 2025: 79 · 2024: 76 · 2023: 84 · 2022: 94 · 2021: 113 · 2020: 108 · 2019: 83 · 2018: 97 · 2017: 94 · 2016: 86 · 2015: 91 · 2014: 77 · 2013: 79 · 2012: 7
- FWCI
- 8.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Calcium signaling and nucleotide metabolism
- Keywords
- poly(ADP-ribosyl)ation, poly(ADP-ribose), PARP1, PARP2, PARP family, protein modification, signal transduction, gene expression regulation, PARP inhibitors
- MeSH terms
- Animals, Catalysis, Cell Nucleus, Cherubism, Cytoplasm, Gene Expression Regulation, Humans, Models, Molecular, Poly Adenosine Diphosphate Ribose, Poly(ADP-ribose) Polymerases, Polymers, Protein Conformation, Protein Processing, Post-Translational, RNA, Signal Transduction, Protein Structure, Tertiary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.